PCMC
DNA icon

Planning Capital Management Corporation’s Ginkgo Bioworks DNA Stock Holding History

Planning Capital Management Corporation’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$180 Buy
22
+19
+633% +$190 ﹤0.01% 705
2024
Q2 		$34 Buy
+3
New +$90 ﹤0.01% 692

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Planning Capital Management Corporation's DNA Position: Q3 2024 in Review

Planning Capital Management Corporation increased its Ginkgo Bioworks (DNA) stake by 633% in Q3 2024, buying an estimated $190 and bringing the position to 22 shares worth $180. The position accounts for ﹤0.01% of the portfolio, ranked #705.

Planning Capital Management Corporation first reported a position in DNA in Q2 2024 and has held it in 2 quarters since. 158 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Planning Capital Management Corporation held 22 shares of Ginkgo Bioworks worth $180 as of Q3 2024.
  • Planning Capital Management Corporation bought 19 Ginkgo Bioworks shares in Q3 2024, an estimated $190.
  • Ginkgo Bioworks made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #705 holding.
  • Planning Capital Management Corporation first reported a position in Ginkgo Bioworks in Q2 2024 and has held it in 2 quarters since.
  • 158 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.